Melanoma-associated antigen C2
Melanoma-associated antigen C2 (336-344) is a synthetic peptide fragment derived from the MAGE-C2 protein, a member of the melanoma-associated antigen gene family. This peptide sequence represents an epitope region that is frequently recognized by cytotoxic T lymphocytes in various studies of tumor immunology. As a defined peptide antigen, it plays a significant role in the investigation of tumor-specific immune responses, particularly in the context of cancer biology and antigen presentation. Its relevance is underscored by its utility in dissecting the molecular interactions between tumor cells and the immune system, making it a valuable tool in both basic and applied research settings focused on cancer immunology, peptide-based immunoassays, and epitope mapping.
Immunological research: The peptide is widely used in studies aiming to characterize cellular immune responses against melanoma and other cancers expressing MAGE-C2. By serving as a defined epitope, it enables researchers to assess T cell recognition, activation, and specificity in vitro. Experiments utilizing this peptide can elucidate the mechanisms by which cytotoxic T lymphocytes identify and respond to tumor cells, supporting the development of immunological models that reflect real-world tumor-immune dynamics.
Epitope mapping and T cell assay development: Melanoma-associated antigen C2 (336-344) is instrumental in the precise mapping of immunodominant epitopes within the MAGE-C2 protein. By incorporating this peptide into T cell assays such as ELISPOT, intracellular cytokine staining, or tetramer-based flow cytometry, scientists can quantify and characterize antigen-specific T cell populations. These approaches are essential for validating the immunogenicity of MAGE-C2-derived sequences and for identifying candidate epitopes for further study.
Antigen processing and presentation studies: The defined sequence of this peptide allows for controlled investigations into the mechanisms of antigen processing and presentation by major histocompatibility complex (MHC) molecules. Researchers can use it to probe the efficiency of peptide loading onto MHC class I molecules, analyze the stability of peptide-MHC complexes, and investigate the factors influencing epitope display on tumor cells. Such studies contribute to a deeper understanding of how tumor antigens are presented to the immune system and the potential for immune evasion.
Peptide-based screening platforms: The peptide serves as a standardized reagent in the development and validation of high-throughput screening assays aimed at identifying T cell receptor (TCR) specificity, cross-reactivity, or immune repertoire diversity. By integrating it into peptide libraries or multiplexed assay systems, investigators can efficiently screen for antigen-specific T cell responses across different donor samples or experimental conditions. This application is particularly valuable in translational research seeking to bridge basic immunology with applied therapeutic discovery.
Peptide synthesis and structural studies: As a well-characterized segment of the MAGE-C2 protein, the peptide is also used as a model substrate in peptide synthesis optimization and structural biology research. Its defined sequence and immunological relevance make it suitable for evaluating synthetic peptide production methods, analyzing peptide conformation, and studying peptide-MHC or peptide-antibody interactions using biophysical techniques. Insights gained from such studies inform the rational design of peptide-based reagents and support advancements in peptide chemistry and immunotechnology.
1. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy
2. An Open-label, Single-center, Safety and Efficacy Study of Eyelash Polygrowth Factor Serum
4. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More